ccfDNA 101: Emerging Trends in Oncology Research
Get Involved With Our Webinars
Doug White graduated from University of Wisconsin Madison with a Master’s Degree in Biochemistry and has been a Promega scientist for 25 years. While at Promega, he’s developed multiple key products including PepTag®, IsoQuant®, PureYield™ Midi and Maxipreps, and various ReliaPrep™ Nucleic Acid Purification Kits.
Tuesday, July 30, 2019
ccfDNA Webinar Series: The Basics and Beyond
Research in circulating cell-free DNA (ccfDNA) has become a key area of interest in the study of normal and disease states.
In Part 1 of 3 ccfDNA webinars, we will build upon the basics of ccfDNA and discuss topics, such as:
- The history of ccfDNA
- How do laboratories commonly extract ccfDNA
- What are typical applications for ccfDNA
Don't forget to register to the next parts of the series:
Part 2 - ccfDNA Workflows: Honing in on the Target
Part 3 - ccfDNA In the Lab: Optimizing Purification for Sequencing
Circulating cell-free DNA (ccfDNA) found in plasma and other bodily fluids shows great promise as a source of easily accessible DNA-based information. Research is giving rise to the possibility of liquid biopsies that would eliminate the need for invasive tissue collection. We will discuss ccfDNA in relation to the other molecules commonly referred to as liquid biopsy. When working with ccfDNA there are many considerations and we will discuss factors for sample collection from blood, expected recovery (yields) of ccfDNA and thoughts on the detection of rare events given expected yields and the frequency of mutational events vs. the sensitivity of various downstream assays.